相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
C. J. Garwood et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
Plasma neurofilament light chain levels in Alzheimer's disease
Wenjun Zhou et al.
NEUROSCIENCE LETTERS (2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2017)
Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
Aiko Ishiki et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer's Disease
Andreas Nabers et al.
ANALYTICAL CHEMISTRY (2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Jonathan D. Rohrer et al.
NEUROLOGY (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
Tobias Skillback et al.
BRAIN (2015)
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Willem Kamphuis et al.
NEUROBIOLOGY OF AGING (2014)
Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
Christoph A. Mayer et al.
PLOS ONE (2013)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Frontotemporal Lobar Degeneration Epidemiology, Pathophysiology, Diagnosis and Management
Gil D. Rabinovici et al.
CNS DRUGS (2010)
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Alex E. Roher et al.
ALZHEIMERS & DEMENTIA (2009)
Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
Sarah Jesse et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Cerebral amyloid angiopathy in Lewy body disease
K. A. Jellinger et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia
R Fukuyama et al.
EUROPEAN NEUROLOGY (2001)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
